GRFT-R02 is a unique, highly osteogenic putty. This patented biomaterial is expected to allow surgeons to address difficult surgical situations like acetabular reconstruction, spinal postero-lateral fusion, non-union or complex cases of fracture healing with poor vascularization. GRFT-R02 shows osteoinductive properties to enhance bone regeneration and is able to repair a critical and segmental bone defects in animal models.
GRFT-M03 is a new generation of highly injectable calcium phosphate cement designed to boost bone reconstruction (with high resorption properties).
GRFT-M04 project is a combination device associating a bone resorption inhibitor (bisphosphonate), a highly injectable calcium phosphate cement and a radio opacifier for the spinal applications.
GRF-M05 project features an innovative Gallium-doped calcium phosphate cement with antitumoral and antimicrobial properties. Targeted indications include bone tumors resections and bone metastases. This project is based upon a next generation technology where the therapeutic agent is included in the crystal structure of the biomaterial.